Tags

Type your tag names separated by a space and hit enter

[The historic role of insulin in the physiopathology of the metabolic complications from pancreatic diabetes. Therapeutic implications for somatostatin].
C R Acad Hebd Seances Acad Sci D. 1975 May 26; 280(20):2353-6.CR

Abstract

Possible ways in which somatostatin may influence the secretion of glucagon and insulin are discussed. The fact that it is possible to maintain normal blood glucose levels in pancreatectomised animals and in juvenile diabetics totally lacking in insulin, solely by the administration of somatostatin, is emphasised.

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

fre

PubMed ID

807423

Citation

Guillemin, R, and M Fontaine. "[The Historic Role of Insulin in the Physiopathology of the Metabolic Complications From Pancreatic Diabetes. Therapeutic Implications for Somatostatin]." Comptes Rendus Hebdomadaires Des Seances De l'Academie Des Sciences. Serie D: Sciences Naturelles, vol. 280, no. 20, 1975, pp. 2353-6.
Guillemin R, Fontaine M. [The historic role of insulin in the physiopathology of the metabolic complications from pancreatic diabetes. Therapeutic implications for somatostatin]. C R Acad Hebd Seances Acad Sci D. 1975;280(20):2353-6.
Guillemin, R., & Fontaine, M. (1975). [The historic role of insulin in the physiopathology of the metabolic complications from pancreatic diabetes. Therapeutic implications for somatostatin]. Comptes Rendus Hebdomadaires Des Seances De l'Academie Des Sciences. Serie D: Sciences Naturelles, 280(20), 2353-6.
Guillemin R, Fontaine M. [The Historic Role of Insulin in the Physiopathology of the Metabolic Complications From Pancreatic Diabetes. Therapeutic Implications for Somatostatin]. C R Acad Hebd Seances Acad Sci D. 1975 May 26;280(20):2353-6. PubMed PMID: 807423.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [The historic role of insulin in the physiopathology of the metabolic complications from pancreatic diabetes. Therapeutic implications for somatostatin]. AU - Guillemin,R, AU - Fontaine,M, PY - 1975/5/26/pubmed PY - 1975/5/26/medline PY - 1975/5/26/entrez SP - 2353 EP - 6 JF - Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles JO - C R Acad Hebd Seances Acad Sci D VL - 280 IS - 20 N2 - Possible ways in which somatostatin may influence the secretion of glucagon and insulin are discussed. The fact that it is possible to maintain normal blood glucose levels in pancreatectomised animals and in juvenile diabetics totally lacking in insulin, solely by the administration of somatostatin, is emphasised. UR - https://www.unboundmedicine.com/medline/citation/807423/[The_historic_role_of_insulin_in_the_physiopathology_of_the_metabolic_complications_from_pancreatic_diabetes__Therapeutic_implications_for_somatostatin]_ L2 - http://www.diseaseinfosearch.org/result/2236 DB - PRIME DP - Unbound Medicine ER -